← Open Payments lookup

PATRICK APILADO: Open Payments

NPI 1982114070 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,191 in 150 payments from 15 companies in 2025. Trend: 2023 $3,451 · 2024 $3,426 · 2025 $3,191

Food & beverage: $3,081Education: $110
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.36$681
E.R. Squibb & Sons, L.L.C.23$435
Alkermes, Inc.19$341
Teva Pharmaceuticals USA, Inc.8$301
Neurocrine BioSciences, Inc.14$288
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$283
ABBVIE INC.9$251
Vanda Pharmaceuticals Inc.6$178
Janssen Pharmaceuticals, Inc8$172
Axsome Therapeutics, Inc.4$91

Products named: REXULTI, COBENFY, ARISTADA, INGREZZA, CAPLYTA, VRAYLAR, FANAPT, SPRAVATO.

Industry payments across NV — which companies pay providers there.